SCHEMBL21716422

SCHEMBL21716422

c1ccc2c(-n3c4ccccc4c4ccccc43)c3c4ccccc4n(-c4nc(-c5ccc6oc7ccccc7c6c5)nc5ccccc45)c3cc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.38
CYP1A2 P05177 8/20 0.36
CYP3A4 P08684 8/20 0.36
CYP2D6 P10635 7/20 0.36
ALDH1A1 P00352 3/20 0.36
ALOX15 P16050 1/20 0.36
ROCK2 O75116 2/20 0.36
ROCK1 Q13464 1/20 0.36
PKN1 Q16512 1/20 0.36
PKN2 Q16513 1/20 0.36
HSD17B10 Q99714 3/20 0.34
CYP2C19 P33261 3/20 0.34
USP2 O75604 3/20 0.34
CLK4 Q9HAZ1 2/20 0.34
ACP1 P24666 2/20 0.33
LMNA P02545 4/20 0.33
TP53 P04637 3/20 0.33
TSHR P16473 5/20 0.32
MAPT P10636 3/20 0.32
MAPK1 P28482 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21717187 0.96 CHEK2 (0.36) CHEK2CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL21716352 0.93 CHEK2 (0.35) CHEK2CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL21717683 0.92 CHEK2 (0.34) CHEK2CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL21717361 0.88 CHEK2 (0.38) CHEK2CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL21213076 0.86 CHEK2 (0.41) CHEK2CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL21717451 0.86 CYP1A2 (0.33) CYP1A2CYP3A4CYP2D6ALDH1A1ALOX15
SCHEMBL21716890 0.86 CHEK2 (0.36) CHEK2ALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL21716792 0.84 MEN1 (0.34) CHEK2MEN1KMT2A
SCHEMBL21716419 0.83 ROCK2 (0.35) CYP1A2CYP3A4CYP2D6ALDH1A1ALOX15
SCHEMBL21717175 0.83 CYP1A2 (0.31) CYP1A2CYP3A4CYP2D6ALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 CHEK2 2353/4885CYP1A2 6/4885CYP3A4 10/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 CHEK2 2353/4885CYP1A2 6/4885CYP3A4 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.